Oak Street Health, Inc. (OSH) Financial Statements (2024 and earlier)
Company Profile
| Business Address |
30 W. MONROE ST., STE. 1200 CHICAGO, IL 60603 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 80 - Health Services (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 3/31/2023 MRQ | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 426 | |||||
| Cash and cash equivalents | 138 | |||||
| Short-term investments | 288 | |||||
| Restricted cash and investments | 21 | |||||
| Receivables | 897 | |||||
| Prepaid expense | 16 | 1 | ||||
| Intangible current assets | 4 | |||||
| Total current assets: | 1,359 | 5 | ||||
| Noncurrent Assets | ||||||
| Operating lease, right-of-use asset | 318 | |||||
| Property, plant and equipment | 204 | |||||
| Intangible assets, net (including goodwill) | 167 | |||||
| Goodwill | 158 | |||||
| Intangible assets, net (excluding goodwill) | 9 | |||||
| Other noncurrent assets | 7 | |||||
| Total noncurrent assets: | 696 | |||||
| TOTAL ASSETS: | 2,055 | 5 | ||||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 70 | |||||
| Accounts payable | 17 | |||||
| Accrued liabilities | 53 | |||||
| Deferred revenue | ||||||
| Other liabilities | 43 | |||||
| Other undisclosed current liabilities | 850 | |||||
| Total current liabilities: | 963 | |||||
| Noncurrent Liabilities | ||||||
| Long-term debt and lease obligation | 979 | 164 | ||||
| Long-term debt, excluding current maturities | 979 | |||||
| Liabilities, other than long-term debt | 380 | |||||
| Other liabilities | 31 | |||||
| Operating lease, liability | 349 | 164 | ||||
| Total noncurrent liabilities: | 1,359 | 328 | ||||
| Total liabilities: | 2,322 | 328 | ||||
| Equity | ||||||
| Equity, attributable to parent | (271) | |||||
| Common stock | 0 | |||||
| Additional paid in capital | 1,205 | |||||
| Accumulated other comprehensive loss | (2) | |||||
| Accumulated deficit | (1,475) | |||||
| Equity, attributable to noncontrolling interest | 4 | |||||
| Total equity: | (267) | |||||
| TOTAL LIABILITIES AND EQUITY: | 2,055 | 328 | ||||
Income Statement (P&L) ($ in millions)
| 3/31/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Revenues | 2,161 | ||||
| Cost of revenue | (2,119) | ||||
| Cost of goods and services sold | (438) | ||||
| Liability for future policy benefits, period expense (income) | (1,645) | ||||
| Gross profit: | 42 | ||||
| Operating expenses | (508) | (21) | |||
| Operating loss: | (466) | (21) | |||
| Nonoperating expense | (43) | ||||
| Other nonoperating expense | (41) | ||||
| Interest and debt expense | (4) | (4) | |||
| Loss from continuing operations before equity method investments, income taxes: | (514) | (25) | |||
| Other undisclosed income from continuing operations before income taxes | 4 | ||||
| Loss from continuing operations before income taxes: | (510) | (25) | |||
| Income tax expense (benefit) | (0) | 2 | |||
| Other undisclosed loss from continuing operations | |||||
| Loss from continuing operations: | (510) | (23) | |||
| Loss before gain (loss) on sale of properties: | ✕ | (23) | ✕ | ||
| Other undisclosed net loss | (392) | ||||
| Net loss: | (510) | (415) | |||
| Net income (loss) attributable to noncontrolling interest | 1 | ||||
| Net loss available to common stockholders, diluted: | (509) | (415) | |||
Comprehensive Income ($ in millions)
| 3/31/2023 TTM | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|
| Net loss: | (510) | (415) | |||
| Other undisclosed comprehensive income (loss) | (1) | (1) | |||
| Comprehensive loss: | (511) | (416) | |||
| Comprehensive income (loss), net of tax, attributable to noncontrolling interest | 1 | 5 | |||
| Comprehensive loss, net of tax, attributable to parent: | (510) | (411) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.